China’s Rise in Drug Development Looms Over U.S.

China’s Rise in Drug Development Looms Over U.S.

DealForma data cited by The New York Times shows China has rapidly become a major source of biopharma dealmaking and oncology innovation, intensifying concerns about U.S. competitiveness in drug development. Read it here

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures